Here you can access all of them with one simple, free registration at the bottom of this page. Or if you already have an Informa Connect account, simply log in below. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.
Cell and Gene Therapies
- Insourcing vs outsourcing in cell and gene therapy manufacturing
- REPORT: Cell and Gene Therapy Analytics, Manufacturing and Supply Chain
- Sourcing and qualification of raw materials for producing cell and gene therapies
- Novel Immuno-Oncology and Immunotherapeutic Approaches
- Cell and Gene Therapies: Viral and Non-Viral Vector Manufacturing
- Research Report: Cell Therapy Process Automation, Scalability and Closed Systems
- Cell therapy bioprocessing: Moving toward commercial scale and efficiency
- The commercialization of cell and gene therapies
- Key regulatory considerations around cell and gene therapies
- Cell and Gene Therapies 2018 - State Of The Industry Report
Peptide and Oligonucleotide Therapeutics
- Partnering in the oligonucleotide and peptide therapeutics industry
- The future of peptide vaccines and personalized peptide therapies
- REPORT: State of Oligo, Peptide, mRNA and CRISPR Therapeutics 2019
- CMC approaches to accelerate peptide, oligo and mRNA therapeutics development
- Drug Delivery of Oligonucleotides, Peptides, RNA, mRNA and CRISPR
- Oligo and Peptide Therapeutics 2018: State of the Industry Report
- Regulatory challenges and strategies for oligonucleotide, peptide and mRNA therapeutics
Antibody Engineering and Therapeutics
- Engineering strategies for TCR and CAR-T cell therapies
- Novel technologies and approaches for optimizing antibody discovery
- REPORT: Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics
- Emerging technologies in antibody engineering and therapeutics
- Bispecific antibody engineering and therapeutics
- Novel Immuno-Oncology and Immunotherapeutic Approaches
- The Future of Monoclonal Antibodies
- State of the Antibody Therapeutics Industry Report 2018
Next Generation Protein Therapeutics
- Next Gen protein drug challenges and the latest technologies to overcome them
- Designing novel protein therapeutics and identifying appropriate targets
- Using next gen protein therapeutics over traditional mAbs
Cell Line Development
Microbiome Therapeutics
- The Future Landscape of Microbiome Therapeutics
- The Regulatory Environment of Microbiome-Based Therapies in the US and EU
- Engineering the Human Microbiome: Research and Investment Opportunities
- Microbiome Therapeutics in 2019: State of the Industry Report
- Microbiome Therapeutics: Beyond the Gut
Register or log in to your Informa Connect account below to get access to all of the above pieces.